Blas Frangione

Active 1965–2015

138
Papers
30,749
Citations
100
h-index
138
i10-index

Citations

Citations per year for Blas Frangione1967: 6 citations1968: 6 citations1969: 12 citations1970: 22 citations1971: 5 citations1972: 9 citations1973: 4 citations1974: 8 citations1975: 8 citations1976: 5 citations1977: 12 citations1978: 8 citations1979: 10 citations1980: 23 citations1981: 20 citations1982: 17 citations1983: 18 citations1984: 11 citations1985: 12 citations1986: 31 citations1987: 48 citations1988: 54 citations1989: 76 citations1990: 108 citations1991: 152 citations1992: 145 citations1993: 121 citations1994: 190 citations1995: 220 citations1996: 254 citations1997: 228 citations1998: 201 citations1999: 224 citations2000: 433 citations2001: 332 citations2002: 435 citations2003: 334 citations2004: 454 citations2005: 311 citations2006: 430 citations2007: 261 citations2008: 357 citations2009: 409 citations2010: 415 citations2011: 336 citations2012: 390 citations2013: 234 citations2014: 256 citations2015: 247 citations2016: 249 citations2017: 318 citations2018: 237 citations2019: 608 citations2020: 664 citations2021: 567 citations2022: 473 citations2023: 330 citations2024: 467 citations2025: 233 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,738 citing papers, 34% of this breakdownUnited Kingdom: 761 citing papers, 6.9% of this breakdownChina: 680 citing papers, 6.2% of this breakdownGermany: 537 citing papers, 4.9% of this breakdownJapan: 442 citing papers, 4% of this breakdownItaly: 436 citing papers, 4% of this breakdownCanada: 389 citing papers, 3.5% of this breakdownSweden: 347 citing papers, 3.2% of this breakdownFrance: 338 citing papers, 3.1% of this breakdownAustralia: 319 citing papers, 2.9% of this breakdownIndia: 242 citing papers, 2.2% of this breakdownNetherlands: 233 citing papers, 2.1% of this breakdown
0%34%Other 23%

Fields

  • Medicine61%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Neuroscience13.2%
  • Immunology and Microbiology1.5%
  • Materials Science1.1%
  • Psychology0.6%
  • Other2.8%

Topics

  • Alzheimer's disease research and treatments19.9%
  • Computational Drug Discovery Methods3.9%
  • Prion Diseases and Protein Misfolding3.6%
  • Cholinesterase and Neurodegenerative Diseases3.5%
  • Neuroinflammation and Neurodegeneration Mechanisms2.9%
  • Amyloidosis: Diagnosis, Treatment, Outcomes2.8%
  • Other63.4%

Coauthors

All papers

Open in search
  1. Clearance systems in the brain—implications for Alzheimer disease

    Authors: , , , , , , , , , , , , , , , - Nature Reviews Neurology 2015 cited by 1,668

  2. Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2000 cited by 1,386

  3. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2003 cited by 1,397

  4. Potent Neuroprotective Properties against the Alzheimer β-Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid

    Authors: , , , , , , - Journal of Biological Chemistry 1999 cited by 396

  5. Amyloid ion channels: A common structural link for protein-misfolding disease

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 982

  6. Systemic Catabolism of Alzheimer's Aβ40 and Aβ42

    Authors: , , , , , , , - Journal of Biological Chemistry 2004 cited by 202

  7. GREATER RISK OF ALZHEIMER'S DISEASE IN OLDER ADULTS WITH INSOMNIA

    Authors: , , , , , , , , , , , , - Journal of the American Geriatrics Society 2011 cited by 186

  8. Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type

    Authors: , , , , , , , , - Science 1990 cited by 1,389

  9. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

    Authors: , , , , , - Nature Medicine 1998 cited by 868

  10. Inhibition of Alzheimer β-Fibrillogenesis by Melatonin

    Authors: , , , , , , , - Journal of Biological Chemistry 1998 cited by 335

  11. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid

    Authors: , - Neuroscience Letters 1992 cited by 800

  12. A stop-codon mutation in the BRI gene associated with familial British dementia

    Authors: , , , , , , - Nature 1999 cited by 473

  13. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies

    Authors: , , , , , , - Acta Neuropathologica 2009 cited by 298

  14. Melatonin Reverses the Profibrillogenic Activity of Apolipoprotein E4 on the Alzheimer Amyloid Aβ Peptide

    Authors: , , , , , , , , , , , - Biochemistry 2001 cited by 151

  15. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides

    Authors: , , , , , , , , , , , - Biochemical Journal 2000 cited by 265

  16. Inhibition of Alzheimer's Amyloidosis by Peptides That Prevent β-Sheet Conformation

    Authors: , , , - Biochemical and Biophysical Research Communications 1996 cited by 428

  17. Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

    Authors: , , , , , , - Journal of Neuropathology & Experimental Neurology 2003 cited by 288

  18. Sporadic and Familial Cerebral Amyloid Angiopathies

    Authors: , , , , , , - Brain Pathology 2002 cited by 201

  19. Relationship Between Cyclophilin A Levels and Matrix Metalloproteinase 9 Activity in Cerebrospinal Fluid of Cognitively Normal Apolipoprotein E4 Carriers and Blood-Brain Barrier Breakdown

    Authors: , , , , , - JAMA Neurology 2013 cited by 117

  20. Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis

    Authors: , , , , , , , , , - Amyloid 2005 cited by 338

  21. Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries

    Authors: , , , , , - Journal of Neurochemistry 1996 cited by 221

  22. Circulating amyloid-β peptide crosses the blood–brain barrier in aged monkeys and contributes to Alzheimer's disease lesions

    Authors: , , , , , , - Vascular Pharmacology 2002 cited by 137

  23. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

    Authors: , , , , - 1994 cited by 444

  24. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 428